Since their FDA approval in 2017, CAR-T cell therapies have revolutionized cancer treatment. Yet, challenges like high costs, manufacturing bottlenecks, and regulatory hurdles limit their full potential.
In this white paper, we explore:
Whether you're an investor, corporate leader, or start-up innovator, our insights will help you navigate the complexities of CAR-T therapies and seize strategic opportunities in this evolving landscape.
Get your copy now to join the conversation on the future of cancer care. Together, we can make groundbreaking therapies accessible to all who need them.
Our latest white paper on PPR highlights strategies and frameworks for pandemic preparedness, with a special focus on the challenges faced by low- and middle-income countries.
Whether you’re part of the diagnostics and pharmaceutical sectors, an NGO, or a healthcare stakeholder, this resource offers valuable insights into building more resilient healthcare systems.
Key topics include:
Let’s work together to enhance our global readiness for future health crises!
In today’s evolving investment landscape, Real Estate as an asset class is undergoing a remarkable transformation.
We are pleased to announce that we have just co-published a whitepaper with Eurazeo on Operational Real Estate (OPRE): “Beyond Ownership”.
Real Estate is increasingly perceived as a service, rather than a commodity, reshaping the way we think about RE investments. OPRE sits at the crossroads of Private Equity and Real Estate, offering innovative pathways for unlocking value.
Our whitepaper delves into this trend and explores how investors can leverage these opportunities.